Announcement on Abnormal Fluctuations in Company Stock Price
The company and all members of the board of directors guarantee the content of this information disclosure is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
I. Stock Trading Abnormal Fluctuation Situation
The stock of Jiangsu Hualian Pharmaceutical New Material Co., Ltd. (hereinafter referred to as the "Company") (Stock Code: 301093, Stock Abbreviation: Hualian Shares) experienced a cumulative increase in closing price deviation of 36.54% (exceeding 30%) over three consecutive trading days (August 5, 2026, August 6, 2026, and August 7, 2026). In accordance with the relevant regulations of the Shenzhen Stock Exchange, this constitutes an abnormal fluctuation in stock trading.
II. Company's Attention and Verification of the Situation
Regarding the abnormal fluctuation in the company's stock price, the company's board of directors conducted verification with the company, controlling shareholders, and actual controllers through on-site, telephone, and letter inquiries. The relevant situation is hereby explained as follows: